Background Febrile neutropenia (FN) is a frequent, serious complication of intensive
pediatric chemotherapy regimens. The aim of this trial was to compare quality of life (QOL) …

The treatment for most pediatric malignancies is based on systemic, aggressive
multimodality therapy including systemic antineoplastic and radiation therapy. Although this …

Background: To identify predictors for 2 risk measures—“proven invasive bacterial infection
or culture-negative sepsis (IBD)” and “clinical complications (CC)”—in pediatric cancer …

PAGANINI, Hugo et al. Diagnóstico y tratamiento de la neutropenia febril en niños con
cáncer: Consenso de la Sociedad Latinoamericana de Infectología Pediátrica. Rev. chil …

Background: Severe sepsis is not clinically apparent during the first 24 hours of
hospitalization in most children with cancer and febrile neutropenia (FN), delaying targeted …

BACKGROUND: Febrile neutropenia is a common complication in children undergoing
chemotherapy for malignancies. A microbial agent is only identified in 15–30% of the fever …

Background: Early identification of children with cancer at risk for death during a febrile
neutropenic (FN) episode may increase their possibility for survival. Our aim was to identify …

Progress has been made in the development and validation of rules that attempt ito predict a
low risk (< 10%) of severe infection or clinical complications in patients with cancer, fever …

Purpose To investigate the feasibility of withholding antibiotics and early discharge for
patients with chemotherapy-induced neutropenia and fever at low risk of bacterial infection …

The hospital landscape is shifting to new care models to meet current challenges in
demand, technology, available budgets and staffing. These challenges also apply to the …